Compiled all in one place, read news articles from each of the news categories, about drugs, the pharmaceutical industry, national and international awareness causes, scientific meetings, trending stories and epgonline.org headlines.

Site News

Added 4 hours ago Drug news

FDA grants De Novo clearance for Innovo device for the treatment of stress urinary incontinence.- Atlantic Therapeutics.

Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, announced that the FDA...

Added 4 hours ago Drug news

EU approves Cabometyx for liver cancer.- Ipsen + Exelixis.

Exelixis announced that its partner Ipsen received approval from the European Commission (EC) for Cabometyx (cabozantinib) tablets as a monotherapy...

Added 4 hours ago Drug news

FDA Advisory Committees recommended approval of abuse deterrent reformulation of Roxicodone by the nasal route to manage severe pain.- SpecGx / Mallinckrodt.

SpecGx LLC , a subsidiary of Mallinckrodt plc, that operates its Specialty Generics business, announced that, in a joint meeting,...

Added 4 hours ago Drug news

Updated data from registration enabling NAVIGATOR trial of avapritinib for patients with PDGFRalpha, D842V-driven GIST and in second-, third- and fourth-line for other GIST patients. Blueprint Medicines

Blueprint Medicines Corporation announced updated data for the registration-enabling NAVIGATOR clinical trial of avapritinib, a potent and highly selective KIT...

Added 4 hours ago Drug news

United Therapeutics licenses global rights from Arena Pharma to ralinepag for the treatment of pulmonary arterial hypertension.

Arena Pharmaceuticals, Inc. and United Therapeutics Corporation announced that the companies have entered into a global license agreement for Arena's...

Added 4 hours ago Drug news

TCH-003 study of Nerivio Migra meets primary endpoint in migraine control.- Theranica.

At the annual headache symposium of the American Headache Society, Theranica announces the results of TCH-003, a pivotal study of...

Added 1 day ago Drug news

In phase III KEYNOTE-181 trial, Keytruda meets primary endpoint in oesophageal cancer.- Merck Inc.

Merck Inc announced that the Phase III KEYNOTE-181 trial investigating Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, as monotherapy in the second-line...

Added 1 day ago Drug news

CE mark for Valiant Navion thoracic stent graft system .- Medtronic

Medtronic plc announced it has received CE Mark approval for the Valiant Navion thoracic stent graft system for the minimally...

Added 1 day ago Drug news

TAPPAS phase III trial shows ApoStream effective in capturing tumour cells in angiosarcoma.- Precision for Medicine.

Precision for Medicine and TRACON Pharmaceuticals announced the publication of biomarker results from the TAPPAS phase III clinical trial that...

Added 1 day ago Drug news

FDA accepts rolling submission of V 920 in Ebola Zaire disease.- Merck Inc.

Merck Inc. announced that it has started the submission of a rolling Biologics License Application (BLA) to the FDA for...

Search all news articles